Loss of NF2/Merlin expression in advanced sporadic colorectal cancer

Tamara Cačev1, Gorana Aralica, Božo Lončar

  • 1Division of Molecular Medicine, Ruđer Bošković Institute, Bijenička cesta 54, 10000, Zagreb, Croatia, tcacev@irb.hr.

Abstract

Insights

The NF2/Merlin gene may play a role in sporadic colorectal cancer development. Lower expression and altered protein levels were observed in poorly differentiated tumors, suggesting it as a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The NF2/Merlin gene, initially linked to neurofibromatosis type 2, is increasingly recognized for its broader tumor suppressor functions.
  • Evidence suggests a general involvement of NF2/Merlin in tumorigenesis beyond its association with NF2.

Purpose of the Study:

  • To investigate the role of NF2/Merlin in sporadic colorectal cancer.
  • To analyze NF2/Merlin alterations in colorectal tumor samples.

Main Methods:

  • Loss of heterozygosity (LOH) analysis at the NF2 locus.
  • Quantitative RT-PCR for NF2 and its isoforms (I and II) mRNA expression.
  • Immunohistochemistry and Western blotting for Merlin protein expression.

Main Results:

  • NF2 LOH occurred in 20% of cases, more frequently in larger tumors (>5 cm) and less differentiated tumors.
  • No significant differences in total NF2 and isoform mRNA expression between tumor and normal tissues were found.
  • Lower mRNA expression of total NF2 and isoforms I/II was observed in poorly differentiated tumors.
  • Weak Merlin immunostaining and altered phosphorylation patterns were more common in poorly differentiated and advanced (Dukes' C) tumors.

Conclusions:

  • NF2/Merlin alterations, including LOH and reduced expression/protein levels, are associated with sporadic colorectal cancer progression.
  • NF2/Merlin warrants further investigation as a potential therapeutic target in colorectal cancer management.